Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Chief Op & Financial Officer | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 221,724 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 1,560 · Balance 221,724 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 219,966 |
Reported balance
After 2026-10-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-02 · Sale · Disposed 1,758 · Balance 219,966 F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 218,235 |
Reported balance
After 2026-10-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-10-05 · Sale · Disposed 1,731 · Balance 218,235 F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.
F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 6, 2026 23:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,731 | $19.50 | $33,754.50 |
DisclosureSEC source: 0001853089-26-000009 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,235 F3 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F4 · balance_after: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2026 Filed Oct 6, 2026 23:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,758 | $18.19 | $31,983.82 |
DisclosureSEC source: 0001853089-26-000009 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,966 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2026 Filed Oct 6, 2026 23:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,560 | $18.17 | $28,341.14 |
DisclosureSEC source: 0001853089-26-000009 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 221,724 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 23:04 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 11,636 | $20.11 | $233,970.87 |
DisclosureSEC source: 0001853089-26-000008 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,284 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.25, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 167,604 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 21, 2026 Filed Aug 21, 2026 21:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 11,228 | $20.02 | $224,784.56 |
DisclosureSEC source: 0001853089-26-000007 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,920 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.05, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F4 · balance_after: Includes 167,604 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 21:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,747 | $19.55 | $112,353.85 |
DisclosureSEC source: 0001853089-26-000007 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Op & Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,148 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.50 to $19.67, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:55 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,189 | $18.62 | $40,764.43 |
DisclosureSEC source: 0001853089-26-000006 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,895 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.515 USD to $18.73 USD; the price reported above reflects the weighted average sale price. F4 · balance_after: Includes 167,604 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:55 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,476 | $18.68 | $46,251.18 |
DisclosureSEC source: 0001853089-26-000006 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,084 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.54 USD to $18.79 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 21:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,560 | $16.73 | $26,106.29 |
DisclosureSEC source: 0001853089-26-000005 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,560 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $16.48 USD to $16.955 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 177,141 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 21:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,757 | $16.80 | $29,520.59 |
DisclosureSEC source: 0001853089-26-000005 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,120 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.48 USD to $16.94 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:28 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,189 | $14.65 | $32,078.70 |
DisclosureSEC source: 0001853089-26-000004 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,877 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.84 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 1,395 shares acquired under the SI-BONE, Inc 2018 Employee Stock Purchase Plan on May 15, 2026. F4 · balance_after: Includes 183,921 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:28 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,477 | $14.71 | $36,444.60 |
DisclosureSEC source: 0001853089-26-000004 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,671 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.84 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 22:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,560 | $12.81 | $19,989.37 |
DisclosureSEC source: 0001853089-26-000003 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,148 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $12.41 USD to $13.10 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 193,458 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 22:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,758 | $12.92 | $22,718.28 |
DisclosureSEC source: 0001853089-26-000003 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,708 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.52 USD to $13.08 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,891 | $15.41 | $59,949.80 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 8 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,466 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F8 · price: This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · balance_after: Includes 200,237 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,065 | $15.46 | $47,383.98 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 7 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,357 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.645 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,189 | $15.29 | $33,465.65 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 6 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,422 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $15.14 USD to $15.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 11,104 | $15.36 | $170,549.67 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 5 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,611 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,279 | $15.35 | $19,632.78 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 4 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,715 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.18 USD to $15.54 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 13,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,994 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 13,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,495 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 80,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001853089-26-000002 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,996 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2026, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,552 | $19.63 | $30,465.76 |
DisclosureSEC source: 0001853089-26-000001 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,002 F4 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17th, 2025. F5 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.56 to $19.79, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F6 · balance_after: Includes 136,335 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,729 | $19.67 | $34,014.96 |
DisclosureSEC source: 0001853089-26-000001 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,554 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.48 to $19.83, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:20 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,948 | $19.63 | $38,229.89 |
DisclosureSEC source: 0001853089-26-000001 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,283 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.39 to $19.835, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:24 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 18,542 | $20.15 | $373,539.72 |
DisclosureSEC source: 0001853089-25-000009 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,231 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.25, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 143,116 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 23:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 100 | $20.00 | $2,000.00 |
DisclosureSEC source: 0001853089-25-000008 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 203,773 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 13th, 2024. F3 · balance_after: Includes 143,116 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 23:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,200 | $20.01 | $24,015.96 |
DisclosureSEC source: 0001853089-25-000008 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 203,873 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 13th, 2024. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,185 | $17.44 | $38,099.63 |
DisclosureSEC source: 0001853089-25-000007 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,073 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.32 USD to $17.56 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 143,116 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:03 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,275 | $17.41 | $22,197.50 |
DisclosureSEC source: 0001853089-25-000007 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,258 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.13 USD to $17.55 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,601 | $18.33 | $47,684.91 |
DisclosureSEC source: 0001853089-25-000006 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,533 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 13th, 2024. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $19.00, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 150,203 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 22:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,557 | $14.17 | $22,064.40 |
DisclosureSEC source: 0001853089-25-000005 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,134 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.065 USD to $14.30 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 150,203 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 22:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,754 | $14.22 | $24,948.37 |
DisclosureSEC source: 0001853089-25-000005 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,691 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.105 USD to $14.34 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,185 | $15.55 | $33,985.05 |
DisclosureSEC source: 0001562180-25-005921 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,445 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.395 USD to $15.785 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 156,983 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,276 | $15.59 | $19,895.90 |
DisclosureSEC source: 0001562180-25-005921 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,630 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.42 USD to $15.785 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2025 Filed Jul 8, 2025 00:30 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,695 | $18.43 | $31,242.92 |
DisclosureSEC source: 0001562180-25-005342 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,078 F4 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F5 · balance_after: Includes 164,071 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 02, 2025 Filed Jul 8, 2025 00:30 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,556 | $18.29 | $28,460.17 |
DisclosureSEC source: 0001562180-25-005342 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,773 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.12 USD to $18.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2025 Filed Jul 8, 2025 00:30 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,754 | $18.31 | $32,107.50 |
DisclosureSEC source: 0001562180-25-005342 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,329 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.07 USD to $18.41 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2025 Filed Jul 22, 2025 22:33 UTC Amendment | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 867 | $18.43 | $15,980.89 |
DisclosureSEC source: 0001562180-25-005490 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,906 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. F2 · shares: This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Person on July 7, 2025 to correct an administrative error that incorrectly overstated the number of shares of stock sold by 828 shares. F3 · balance_after: Includes 164,071 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 19, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,424 | $19.48 | $47,212.98 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 8 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,083 F8 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $19.31 USD to $19.68 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · balance_after: Includes 2,023 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2025. F12 · balance_after: Includes 170,852 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,958 | $20.01 | $99,230.40 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 7 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,507 F8 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.04 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 261 | $19.97 | $5,212.85 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 6 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,442 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $19.91 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 307 | $19.92 | $6,113.97 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 5 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,703 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $19.80 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,924 | $19.54 | $37,592.27 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 4 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,010 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $18.91 USD to $19.89 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 968 | $19.26 | $18,641.07 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 3 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,934 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $18.79 USD to $19.68 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,127 | $19.36 | $21,816.02 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,902 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.76 USD to $19.71 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 40 | $19.80 | $792.14 |
DisclosureSEC source: 0001562180-25-004056 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,029 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.80 USD to $19.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:33 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,937 | $19.02 | $93,925.93 |
DisclosureSEC source: 0001562180-25-003848 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,069 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.14, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 180,329 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 08, 2025 Filed May 9, 2025 23:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 28,350 | $18.17 | $515,093.99 |
DisclosureSEC source: 0001562180-25-003726 · primarydocument.xml · nonDerivative · entry 2 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,006 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.00 to $18.37, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F4 · balance_after: Includes 180,329 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 07, 2025 Filed May 9, 2025 23:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,937 | $17.00 | $83,939.37 |
DisclosureSEC source: 0001562180-25-003726 · primarydocument.xml · nonDerivative · entry 1 Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,356 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.03, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.